Healthcare practice strategies for integrating personalized medicine: Management of COVID-19

doi:10.12998/wjcc.v9.i29.8647

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 29

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9253)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

341

WORD

118

HTML

3771

Figures (1-1)

569

Tables (1-1)

564

Sum=5363

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

547

Download

1330

Sum=1877

Publishing Process of This Article

Item

Count

Browse

630

Download

1388

Sum=2018

Oct 16, 2021 (publication date) through Feb 26, 2026

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Minireviews

World J Clin Cases. Oct 16, 2021; 9(29): 8647-8657
Published online Oct 16, 2021. doi: 10.12998/wjcc.v9.i29.8647

Healthcare practice strategies for integrating personalized medicine: Management of COVID-19

Wen-Yi Liu, Ching-Wen Chien, Tao-Hsin Tung

Wen-Yi Liu, Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, MD 21205, United States; Shanghai Bluecross Medical Science Institute, Shanghai 201100, Shanghai Province, China

Wen-Yi Liu, Ching-Wen Chien, Institute for Hospital Management, Tsing Hua University, Shenzhen Campus, Shenzhen 518055, Guangdong Province, China

Tao-Hsin Tung, Evidence-based Medicine Center, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai 317000, Zhejiang Province, China

Author contributions: Liu WY and Tung TH had full assessment for all of the data in the study and take responsibility for the integrity and accuracy of the data; Chien CW contributed to data interpretation and drafting the manuscript; all authors provided a critical review and approved the final manuscript.

Conflict-of-interest statement: The authors have no proprietary interest in any aspect of this review.

Corresponding author: Tao-Hsin Tung, PhD, Director, Evidence-based Medicine Center, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, No. 150 Ximen Road, Linhai City, Linhai 317000, Zhejiang Province, China. ch2876@gmail.com

Received: February 17, 2021
Peer-review started: February 17, 2021
First decision: March 11, 2021
Revised: March 22, 2021
Accepted: August 18, 2021
Article in press: August 18, 2021
Published online: October 16, 2021
Processing time: 240 Days and 8.3 Hours

Abstract

Personalized medicine is the tailor-made clinical treatment to the individual characteristics of each patient. It may be considered an extension of traditional approaches to knowing and treating diseases. Personalized medicine has the potential to change the way of identification and management of health problems. Coronavirus disease 2019 (COVID-19) is an infectious disease that primarily affects the patients’ lungs. The first case of pneumonia of unknown cause was reported in Wuhan, China on December 31, 2019. As thus, we are quickly approaching the era of personalized medicine. This review discusses the practices currently used in the management of COVID-19 and how they relate to personalized medicine.

Keywords: Healthcare; Personalized medicine; COVID-19; SARS-CoV-2

Core Tip: For patients with coronavirus disease 2019 (COVID-19), providing the most effective treatment is a task of paramount importance in personalized medicine. The pandemic of COVID-19 is the opportunity and challenge to change toward a more personalized approach taking patients’ needs into consideration. Personalized medicine related research is ideally suited to dealing with infectious diseases; however, there has been relatively little research in this area.